Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,496
Closed -$662K 614
2025
Q4
$662K Buy
13,496
+4
+0% +$187 0.01% 366
2025
Q3
$582K Buy
13,492
+4
+0% +$156 0.01% 395
2025
Q2
$518K Sell
13,488
-307
-2% -$11.7K 0.01% 394
2025
Q1
$534K Buy
13,795
+398
+3% +$14.6K 0.01% 342
2024
Q4
$453K Buy
13,397
+8,396
+168% +$302K 0.01% 418
2024
Q3
$204K Buy
+5,001
New +$205K ﹤0.01% 715
2023
Q1
Sell
-8,583
Closed -$302K 634
2022
Q4
$302K Sell
8,583
-225
-3% -$7.5K 0.01% 395
2022
Q3
$259K Buy
+8,808
New +$334K 0.01% 398
2022
Q2
Sell
-8,386
Closed -$456K 609
2022
Q1
$456K Buy
8,386
+8
+0.1% +$435 0.02% 259
2021
Q4
$462K Buy
+8,378
New +$436K 0.02% 268

Other funds holding GSK

Forum Financial Management's GSK Position: Q1 2026 in Review

Forum Financial Management sold out of GSK (GSK) in Q1 2026, closing a stake of 13,496 shares — an estimated $662K sold.

Forum Financial Management first reported a position in GSK in Q4 2021 and held it in 10 quarters. The position peaked at $662K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Forum Financial Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 13,496 GSK shares in Q1 2026, an estimated $662K.
  • Forum Financial Management first reported a position in GSK in Q4 2021 and held it in 10 quarters.
  • Forum Financial Management's GSK position peaked at $662K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.